Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study

Lung Cancer ◽  
2014 ◽  
Vol 86 (1) ◽  
pp. 47-53
Author(s):  
Armando Santoro ◽  
Gunnar N. Hillerdal ◽  
Gert Hoeffken ◽  
Adolfo Favaretto ◽  
Ramon Perez Carrion ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Phase 2 ◽  
Small Cell Lung ◽  
First Line ◽  
Phase 2 Study ◽  
First Line Treatment

scholarly journals A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

2013 ◽  
Vol 8 (3) ◽  
pp. 329-337 ◽  
Author(s):  
Luis Paz-Ares ◽  
Beatrix Bálint ◽  
Richard H. de Boer ◽  
Jan P. van Meerbeeck ◽  
Rafal Wierzbicki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Phase 2 ◽  
Small Cell Lung ◽  
First Line ◽  
Phase 2 Study ◽  
Randomized Phase 2 ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document